Grasse, France

Isabelle Carlavan

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Isabelle Carlavan

Introduction

Isabelle Carlavan is a prominent inventor based in Grasse, France. She has made significant contributions to the field of dermatology, particularly in the treatment of skin conditions such as acne and rosacea. With a total of three patents to her name, her work has garnered attention for its innovative approaches to common dermatological issues.

Latest Patents

One of Isabelle's latest patents is focused on Th17 differentiation markers for acne and their uses. This patent describes a method for using ROR gamma t or ROR alpha to diagnose acne and screen inhibitors of Th17 differentiation. Specifically, it outlines methods for inhibiting ROR gamma t or ROR alpha and the use of these screened inhibitors in acne treatment. Another notable patent involves the use of naratriptan in the treatment of rosacea. This patent details a method of using a topical pharmaceutical composition, particularly a dermatological composition, comprising naratriptan to treat rosacea, especially erythematotelangiectatic rosacea.

Career Highlights

Isabelle Carlavan works at Galderma Research & Development, where she continues to innovate in the field of dermatology. Her research and patents reflect her commitment to improving treatment options for patients suffering from skin conditions.

Collaborations

Isabelle has collaborated with notable colleagues, including Michel Rivier and Jerome Aubert, who have contributed to her research endeavors.

Conclusion

Isabelle Carlavan's work exemplifies the impact of innovative thinking in dermatology. Her patents not only advance scientific understanding but also offer new hope for effective treatments for skin conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…